Article
New Orleans - Vaccination with a mixture of 12 peptides was immunogenic in 100 percent of melanoma patients tested, even with multiple peptides competing for the same cell surface binding sites, according to Craig L. Slingluff, Jr., M.D.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.